eClinical Tech News

Roche Reports Robust H1 2025 Performance Driven by Pharmaceutical Growth Roche has announced strong financial results for the first...

Sanofi secures expanded EU approval for Sarclisa in newly diagnosed multiple myeloma, bolstering its presence in the competitive myeloma...

Rakovina Therapeutics is incentivizing early warrant exercises in a move to bolster its cash position and potentially streamline its...

Cabometyx Secures Broad EU Approval for Neuroendocrine Tumors, Reshaping the Treatment Landscape Ipsen’s cabozantinib (Cabometyx) has received European Commission...

Boehringer Ingelheim’s strong first-half 2025 results, with 6.3% net sales growth reaching €14.0 billion, underscore the company’s diversified portfolio...

Roche’s Half-Year Results Showcase Oncology Strength, Pipeline Progress, and Strategic Shifts Roche reported robust 7% sales growth (CER) for...

Roche’s H1 2025 results reveal robust growth driven by strong pharmaceutical sales, underscoring the company’s continued success in navigating...

Bio Usawa Biotechnology and Servaregmp are partnering to establish advanced monoclonal antibody (mAb) manufacturing capabilities in Africa. This ambitious...

ANI Pharmaceuticals announced results from its NEW DAY clinical trial evaluating the supplemental injection needs of patients with diabetic...